We are improving our search experience. To check which content you have full access to, or for advanced search, go back to the old search.

Search

Please fill in this field.

Search Results

Showing 1-20 of 1,967 results
  1. A Rare Case of Metastatic Uterine Leiomyosarcoma to the Thyroid Gland

    Uterine leiomyosarcomas are malignant tumors that have a grim prognosis. These neoplasms have a high metastatic potential. Limited literature exists...

    R. Sathish Kumar, H. Akshaykumar, ... J. Dipin in Indian Journal of Otolaryngology and Head & Neck Surgery
    Article 25 November 2023
  2. Successful clinical approach to the metastatic uterine leiomyosarcoma to the epicardium—a case report

    Background

    Uterine leiomyosarcoma is a rare and aggressive tumour with a poor prognosis. Its metastases to the heart are even rarer, especially to the...

    Kristina Krzelj, Ante Lekic, ... Ivica Safradin in BMC Cardiovascular Disorders
    Article Open access 13 January 2024
  3. Preclinical activity of selinexor in combination with eribulin in uterine leiomyosarcoma

    Leiomyosarcoma (LMS) is a rare soft tissue sarcoma (STS) that begins in smooth muscle tissue and most often initiates in the abdomen or uterus....

    Sonam Mittal, Ishaque Pulikkal Kadamberi, ... Sunila Pradeep in Experimental Hematology & Oncology
    Article Open access 15 September 2023
  4. MRI, clinical, and radiomic models for differentiation of uterine leiomyosarcoma and leiomyoma

    Purpose

    To assess the predictive ability of conventional MRI features and MRI texture features in differentiating uterine leiomyoma (LM) from uterine...

    Lauren A. Roller, Qi Wan, ... Atul B. Shinagare in Abdominal Radiology
    Article 11 March 2024
  5. Prognostic Impact of Tumor-Infiltrating Lymphocytes, Tertiary Lymphoid Structures, and Neutrophil-to-Lymphocyte Ratio in Pulmonary Metastases from Uterine Leiomyosarcoma

    Background

    The presence of tumor-infiltrating lymphocytes (TILs) and tertiary lymphoid structures (TLSs) in tumor tissue has been related to the...

    Naoki Matsuda, Hiromasa Yamamoto, ... Shinichi Toyooka in Annals of Surgical Oncology
    Article Open access 01 September 2023
  6. The therapeutic potential of RNA Polymerase I transcription inhibitor, CX-5461, in uterine leiomyosarcoma

    Background. Uterine leiomyosarcoma is a rare aggressive smooth muscle cancer with poor survival rates. RNA Polymerase I (Pol I) activity is elevated...

    Chang-Won Kang, Katherine M. Hannan, ... Lucy A. Coupland in Investigational New Drugs
    Article Open access 24 February 2022
  7. A novel morphology-based risk stratification model for stage I uterine leiomyosarcoma: an analysis of 203 cases

    Uterine leiomyosarcoma is the most common uterine mesenchymal malignancy. The majority present at stage I, and clinical outcomes vary widely....

    David B. Chapel, Aarti Sharma, ... Marisa R. Nucci in Modern Pathology
    Article 04 February 2022
  8. Diagnostic and prognostic value of Bcl-2 in uterine leiomyosarcoma

    Background

    Uterine leiomyosarcoma (uLMS) may show loss of expression of B-cell lymphoma-2 (Bcl-2) protein. It has been suggested that Bcl-2 loss may...

    Antonio Travaglino, Antonio Raffone, ... Luigi Insabato in Archives of Gynecology and Obstetrics
    Article Open access 28 March 2022
  9. Impact of Intraoperative Tumor Spillage in Uterine Leiomyosarcoma: a Retrospective Single-Institution Analysis

    Uterine leiomyosarcoma is a rare female reproductive system tumor which is difficult to distinguish from uterine leiomyoma preoperatively. Manual and...

    Viral Patel, Anupama Rajanbabu, ... Greeshma C. Ravindran in Indian Journal of Surgical Oncology
    Article 07 August 2021
  10. Pulmonary vein thrombosis associated with metastatic uterine leiomyosarcoma: a case report

    Background

    Pulmonary vein thrombosis (PVT) is rarely associated with malignancies. Leiomyosarcoma, a malignant tumor originating from smooth muscles,...

    Mehdi Salimi, Dena Mohamadzadeh, Mojdeh Bonyadi in Journal of Medical Case Reports
    Article Open access 12 January 2023
  11. Evaluation of Hedgehog Pathway Inhibitors as a Therapeutic Option for Uterine Leiomyosarcoma Using the Xenograft Model

    Uterine leiomyosarcoma (LMS) contributes to a significant proportion of uterine cancer deaths. It is a rare and high-risk gynecological cancer. LMS...

    Natalia Garcia, Mara Ulin, ... Qiwei Yang in Reproductive Sciences
    Article Open access 12 October 2021
  12. Identification of uterine leiomyosarcoma-associated hub genes and immune cell infiltration pattern using weighted co-expression network analysis and CIBERSORT algorithm

    Background

    While large-scale genomic analyses symbolize a precious attempt to decipher the molecular foundation of uterine leiomyosarcoma (ULMS),...

    **aoqing Shen, Zhujuan Yang, ... Yi Li in World Journal of Surgical Oncology
    Article Open access 28 July 2021
  13. TEM1 up-regulates MMP-2 and promotes ECM remodeling for facilitating invasion and migration of uterine sarcoma

    Objectives

    To explore the correlation between tumor endothelial marker 1 (TEM1) and matrix metalloproteinase 2 (MMP-2) in uterine sarcoma and their...

    Chenghao Wu, Wenhuizi Sun, ... Yi Guo in Discover Oncology
    Article Open access 13 January 2023
  14. The values of Transgelin, Stathmin, BCOR and Cyclin-D1 expression in differentiation between Uterine Leiomyosarcoma (ULMS) and Endometrial Stromal Sarcoma (ESS); diagnostic and prognostic implications

    Background

    Morphologic distinction between uterine leiomyosarcoma (ULMS) and endometrial stromal sarcoma (ESS) alone is not straightforward and has...

    Mohamed Ali Alabiad, Ola A. Harb, ... Elsayed I. El-Hendawy in Surgical and Experimental Pathology
    Article Open access 11 June 2020
  15. Malignant perivascular epithelioid cell tumor (PEComa) of the uterus

    Background

    Perivascular epithelioid cell tumors (PEComas) of the uterus is a rare type of mesenchymal tumors associated with myelomelanocytic...

    Bo Cao, Yi Huang in BMC Women's Health
    Article Open access 16 December 2022
  16. Sarcoma of the uterine cervix: experience of a single center

    Objectives

    To investigate the clinicopathological characteristics and prognosis of patients with primary sarcoma of the uterine cervix.

    ...
    Hua Yuan, Lihong Li, ... Hongwen Yao in World Journal of Surgical Oncology
    Article Open access 18 April 2024
  17. Percutaneous Uterine Needle Biopsy with Microscopic and Array-CGH Analyses for Preoperative Sarcoma Diagnosis in Patients with Suspicious Myometrial Tumors on MRI: A Prospective Pilot Study (SARCGYN)

    Background

    Unlike for soft tissue sarcomas, percutaneous biopsy is not validated for uterine myometrial tumors, leading to leiomyosarcoma inadvertent...

    Jeremy Smadja, Sophie El Zein, ... Sylvie Bonvalot in Annals of Surgical Oncology
    Article 26 October 2022
  18. Benign metastasizing fumarate hydratase (FH)-deficient uterine leiomyomas: clinicopathological and molecular study with first documentation of multi-organ metastases

    Leiomyoma is the most prevalent benign tumor of the female reproductive system. Benign metastasizing leiomyoma (BML) is a rare phenomenon that...

    **aoxue Yin, **aoxia Wei, ... Ni Chen in Virchows Archiv
    Article Open access 20 April 2024
Did you find what you were looking for? Share feedback.